Care for public health and focus on patients' need.
Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd., founded in 1991, is a wholly-owned subsidiary of China Resources Sanjiu Pharmaceuticals Co., Ltd. (CR SANJIU), and also an anti-infection business division and a peri-operative period platform of CR SANJIU. The headquarters of the business division is located at No. 2 Kaifeng Road, Meilin Sub-district, Futian District, Shenzhen. Our corporation has an annual sale income of more than RMB 2 billion, and is an enterprise integrating research and development, production and marketing of active pharmaceutical ingredients (APIs), and oral and injection preparations, composed of Shenyang China Resources Sanjiu Pharmaceutical Co., Ltd., Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Co., Ltd, Zhejiang China Resources Jiuzhong Pharmaceutical Co., Ltd, and Shenzhen China Resources Jiuchuang Pharmaceutical Co., Ltd.
CR Gosun and its subsidiaries currently have products includs cephalosporin injections. The leading product, “Xin Tai Lin®” (Cefazolin Sodium Pentahydrate for Injection), is a patent product researched and developed jointly by Academician Wang Jingkang from the Chinese Academy of Engineering, an expert in industrial crystallization, and a professor working with Chemical Department of Tianjin University, and National Institute for Food and Drug Control and CR Gosun. The product once won the second National Prize of Progress in Science and Technology and two national patents and three international ones, and was recorded in Interpretation of Clinical Pathway and Therapeutic Drugs. Xin Tai Lin® is mainly used as a preventive drug for surgeries, and also used for treatment of infective diseases caused by susceptible bacteria. Its clinical application of 15 years has shown its significant efficacy and high safety, and it has been appraised positively by clinical physicians and patients.
Now, CR Gosun is expanding its pipeline to perioperative treatment.
CR Gosun and our subsidiary, Shenyang Sanjiu Pharmaceutical, Co., Ltd., have a total annual productivity of 450 tons of sterile cephalosporin powder, possess two production lines of APIs, and four automatic modernized production lines for powder injections, and have the capacity of an annual productivity of 0.2 billion pieces of powder injections. Our main products include over 30 drugs, such as Cefazolin Sodium Pentahydrate for Injection, Cefuroxime Sodium for Injection, Cefonicid Sodium for injection. Cefotaxime Sodium for Injection, Ceftezole Sodium for Injection, and etc. We manufacture sterile APIs and intermediates at the same time, and the product quality has reached the international advanced level.
CR Gosun is the first pharmaceutical manufacturer in China passing the French GMP certification for sterile drug products, one of the first 50 GMP- compliance manufacturers in the domestic pharmaceutical industry approved by SFDA, one of the first batch of “national high-tech enterprises”, and once won the second National Prize of Progress in Science and Technology and Chinese Excellent Patent Award. Our corporation was once appraised to be Excellent Foreign-Invested Enterprises across China, Top 100 Enterprises in Shenzhen, independent innovation enterprises, Leading Enterprises with Drug Product Internationalization of Chinese Pharmaceutical Enterprises, and the Most Competitive Enterprise in Chinese Pharmaceutical Industry. CR Gosun actively strives for top quality, high efficacy and high safety. In March 2020, our corporation passed advanced AEO certification of the customs, indicating that our corporation runs in an important development way to internationalization completely.
For twenty years, CR Gosun has been accepted well by cooperative partners due to its products with high reliability, quality, safety and efficacy. From 2012, CR Gosun has achieved strategic cooperation with Roche (Shanghai), and signed a cooperative agreement on CMO of Rocephin. In 2019, we together with Roche promoted an internationalized high-end manufacturing cooperation project, and now we are walking in the biopharmaceutical industry gradually. At present, CR Gosun and our subsidiaries have established good international cooperation with famous pharmaceutical corporations in Germany, France, England, Italy, Spain, Southeast Asia, North America, South America and Africa.
